Abbott Laboratories is a dividend growth machine that's known for consistency. AbbVie's dividend has more than quadrupled ...

Tremfya snagged Dupixent’s place as the pharma brand with the most TV impressions in June, according to data released by iSpot.tv on Friday morning. The Johnson & Johnson brand garnered a 4.3% share ...

Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a ...

The shares of Glenmark Pharmaceutical Ltd increased 10% on Friday to hit a 52-week high after the company announced that its subsidiary had signed an exclusive license agreement with American ...

Today's rally followed Glenmark's Thursday announcement that its innovation arm, Ichnos Glenmark Innovation (IGI), has ...

IGI has partnered with AbbVie to grant exclusive rights to globally develop, manufacture, and commercialise ISB 2001 across ...

HSBC and Axis Capital are more bullish on its transformative impact and future growth prospects for Glenmark, while Nuvama ...

Stocks including TCS, Hindustan Unilever, Glenmark Pharma, IREDA, Tata Elxsi, Anand Rathi Wealth, Birla Corp, Zee ...

Shares of Glenmark Pharmaceuticals jumped 10% in early trade on Friday, a day after a unit of the Indian drugmaker signed an exclusive licensing deal with U.S. peer AbbVie for its cancer treatment.

Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced several strategic leadership appointments within its Drug Product team. These ...

Trump's moves have raised fears that economic growth would slow to a trickle, if not make the U.S. and other nations more ...